Crotamiton 100 MG/ML Topical Lotion — RxCUI 106219
RxNorm drug concept · Semantic clinical drug
RxCUI 106219
Semantic clinical drug · SCD
● Current RxNorm concept 2 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI106219
Official nameCrotamiton 100 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascrotamiton 10 % Topical Lotion
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)2,431 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Crotamiton 100 MG/ML Topical Lotion Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Crotamiton 100 MG/ML Topical Lotion
RxCUI 106219 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Crotamiton
21766IN
-
Crotamiton
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Crotan
2049599BN -
Eurax
202842BN
-
Crotan
-
Dose forms 8
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Crotamiton Topical Lotion
377882SCDF -
Crotamiton Topical Product
1165621SCDG -
Crotamiton Topical Lotion [Crotan]
2049601SBDF -
Crotamiton Topical Lotion [Eurax]
365784SBDF -
Crotan Topical Product
2049602SBDG -
Eurax Topical Product
1171131SBDG -
Topical Lotion
316983DF -
Topical Product
1151122DFG
-
Crotamiton Topical Lotion
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Crotamiton 100 MG/ML
343129SCDC -
Crotamiton 100 MG/ML Topical Lotion [Crotan]
2049603SBD -
Crotamiton 100 MG/ML Topical Lotion [Eurax]
207894SBD -
Crotamiton 100 MG/ML [Crotan]
2049600SBDC -
Crotamiton 100 MG/ML [Eurax]
568597SBDC
-
Crotamiton 100 MG/ML
Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Crotamiton 100 MG/ML
SCDC · 343129 -
Crotamiton Topical Lotion
SCDF · 377882 -
Crotamiton Topical Product
SCDG · 1165621
Brand-Name Concepts
-
Crotamiton 100 MG/ML Topical Lotion [Crotan]
SBD · 2049603 -
Crotamiton 100 MG/ML Topical Lotion [Eurax]
SBD · 207894 -
Crotamiton 100 MG/ML [Crotan]
SBDC · 2049600 -
Crotamiton 100 MG/ML [Eurax]
SBDC · 568597 -
Crotamiton Topical Lotion [Crotan]
SBDF · 2049601 -
Crotamiton Topical Lotion [Eurax]
SBDF · 365784 -
Crotan Topical Product
SBDG · 2049602 -
Eurax Topical Product
SBDG · 1171131 -
Crotan
BN · 2049599 -
Eurax
BN · 202842
📦 FDA Products & Package NDCs
2 products · 4 package NDCs
4 package NDCs map to RxCUI 106219 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00682-0051-10 | 237 g in 1 BOTTLE, PLASTIC (0682-0051-10) | Crotan | Marnel Pharmaceuticals, Inc. | 2022-01-15 |
| 00682-0051-20 | 60 g in 1 BOTTLE, PLASTIC (0682-0051-20) | Crotan | Marnel Pharmaceuticals, Inc. | 2022-01-15 |
| 00682-0051-30 | 454 g in 1 BOTTLE, PLASTIC (0682-0051-30) | Crotan | Marnel Pharmaceuticals, Inc. | 2022-01-15 |
| 73352-0051-10 | 237 g in 1 BOTTLE, PLASTIC (73352-051-10) | Pruradik | Trifluent Pharma, LLC | 2025-06-02 |
Observed labelers:
Marnel Pharmaceuticals, Inc. (3) ·
Trifluent Pharma, LLC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$3.1167
Range $3.1167–$3.1167
· middle 50% $3.1167–$3.1167
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.